Dr. Bogi Andersen, MD

Dr. Andersen practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Andersen's NPI, 1164502233, was assigned on October 16, 2006. Dr. Andersen graduated from University of Iceland in 1981. Dr. Andersen holds California license 000000A48338.

Dr. Andersen's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Andersen's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Andersen to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Andersen practices, 2 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Andersen's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Andersen is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Andersen's licenses on file in 2 states: California and Ohio.

Dmand AI lists chronic diabetes, chronic hypertension, diabetic emergency, enlarged thyroid, high cholesterol, obesity, osteoporosis and overactive thyroid among the conditions Dr. Andersen treats.

CMS data shows 216 Medicare services from Dr. Andersen across 4 procedure codes in 2024, for 132 Medicare patients. Medicare paid $17,076 for them.

CMS counts 132 Medicare patients who saw Dr. Andersen in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Andersen's median patient age at 63, with 52% women.

In 2024, Dr. Andersen wrote 494 Medicare Part D claims for 61 patients. 37% of them were for generic drugs. CMS names the drug for 306 of them, across 11 drugs with 11 or more claims each, at $202,414 in total drug cost. In 2023, CMS named 254 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Andersen for performance year 2024, reported through an alternative payment model (APM). Dr. Andersen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Andersen as offering telehealth.

Dmand AI links 82 papers to Dr. Andersen, published from 2004 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Transcription Factors, DNA-Binding Proteins and Skin. Dr. Andersen has published most often in J Invest Dermatol. Dr. Andersen's most frequent co-authors are Vivek Kumar, MD, Raul Ramos, MD and Sergei A. Grando, MD, PhD.

CMS Open Payments shows 1 general payment to Dr. Andersen from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Tactile Systems Technology Inc paid the most, $71.

Dmand AI lists 1 award for Dr. Andersen, most recently Regional Top Doctor in 2014.

Dr. Andersen graduated from University of Iceland in 1981.

Dr. Andersen is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.